...
首页> 外文期刊>Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis >All three receptors for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells.
【24h】

All three receptors for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells.

机译:血管内皮生长因子(VEGF)的所有三种受体都在B慢性淋巴细胞性白血病(CLL)细胞上表达。

获取原文
获取原文并翻译 | 示例

摘要

B-chronic lymphocytic leukemia (B-CLL) cells have a long survival owing to an alteration in the normal pathways of apoptosis. CLL cells have been found to produce and secrete vascular endothelial growth factor (VEGF). In addition to its major role in angiogenesis, VEGF affects cell survival by interfering with apoptosis. The aim of the present study was to investigate the expression of the VEGF receptors VEGFR-1, VEGFR-2, and VEGFR-3 on B-CLL cells, singly and combined. B-CLL cells were isolated from peripheral blood drawn from patients with CLL. Total VEGF receptor, examined in 13 samples by flow cytometry was present in all cases with mean CD19+/VEGF+ expression of 76% (range 52-92%). Specific receptor expression, examined in 27 samples by immunocytochemical methods, was positive for VEGFR-1 in all 27 patients and for VEGFR-2 and VEGFR-3 in 26 (96%). These findings suggest that the VEGF transduction pathway may be very active in CLL cells, and both its paracrine and autocrine pathways may contribute to their enhanced survival.
机译:B慢性淋巴细胞性白血病(B-CLL)细胞由于正常凋亡途径的改变而具有长生存期。已经发现CLL细胞产生并分泌血管内皮生长因子(VEGF)。除了在血管生成中的主要作用外,VEGF还通过干扰细胞凋亡来影响细胞存活。本研究的目的是单独和联合研究VEGF受体VEGFR-1,VEGFR-2和VEGFR-3在B-CLL细胞上的表达。从CLL患者的外周血中分离出B-CLL细胞。在所有情况下,均通过流式细胞术检查了13个样品中的总VEGF受体,平均CD19 + / VEGF +表达为76%(范围52-92%)。通过免疫细胞化学方法在27个样品中检测到的特异性受体表达在所有27例患者中均为VEGFR-1阳性,在26例中为VEGFR-2和VEGFR-3阳性(96%)。这些发现表明VEGF转导途径在CLL细胞中可能非常活跃,其旁分泌和自分泌途径均可能有助于其存活。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号